Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1 1

Status

Completed 6Recruiting 5Withdrawn 3Unknown 3Active not recruiting 3Terminated 1Not yet recruiting 1

Sponsor Class

OTHER 2NETWORK 1

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 1Other hematologic neoplasm 1Head & Neck 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1Hematologic Neoplasms 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Cisplatin 517Radiotherapy 378Cyclophosphamide 368Carboplatin 359Capecitabine 342Paclitaxel 337Oxaliplatin 336Gemcitabine 322Docetaxel 317Fluorouracil 290Drug Therapy 276Bevacizumab 248apatinib 247camrelizumab 219Etoposide 201Irinotecan 182Doxorubicin 181Leucovorin 163Dexamethasone 161pembrolizumab 153Neoadjuvant Therapy 146sintilimab 145anlotinib 140Blood Specimen Collection 140Pemetrexed 138Cytarabine 138toripalimab 133Surgical Procedures, Operative 131Radiosurgery 131S 1 (combination) 125

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × monalizumab × Clear all
NCT03833440 2024-05-03

PIONeeR

Assistance Publique Hopitaux De Marseille

Phase 2 Unknown
114 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT03088059 2023-11-03

UPSTREAM

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Unknown
340 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck

NCT02921685 2018-09-19

PIRAT

Institut Paoli-Calmettes

Phase 1 Unknown
18 enrolled
Other hematologic neoplasm

Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡